GlaxoSmithKline PLC Director/PDMR Shareholding (7167X)
24 February 2017 - 1:57AM
UK Regulatory
TIDMGSK
RNS Number : 7167X
GlaxoSmithKline PLC
23 February 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr S Dingemans
=== =============================== ==================================================
b) Position/status Chief Financial Officer
=== =============================== ==================================================
c) Initial notification/ Initial Notification
amendment
=== =============================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GlaxoSmithKline plc
=== =============================== ==================================================
b) LEI 5493000HZTVUYLO1D793
=== =============================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
=== =============================== ==================================================
b) Nature of the The exercise of nil-cost options over
transaction Ordinary Shares granted on 12 February
2014 under the Company's 2009 Deferred
Annual Bonus Plan - Deferred Bonus and
Matching Awards.
=== =============================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
=== =============================== ================ ============================
GBP0.0000 22,448 (Deferred)
=== =============================== ================ ============================
GBP0.0000 7,483 (Matching)
================ ============================
,
=== =============================== ================ ============================
d) Aggregated information
===
Aggregated volume 29,931
Price GBP0.0000
=== =============================== ==================================================
e) Date of the transaction 2017-02-22
=== =============================== ==================================================
f) Place of the transaction n/a
=== =============================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================================
a) Name Mr S Dingemans
=== =============================== ====================================================
b) Position/status Chief Financial Officer
=== =============================== ====================================================
c) Initial notification/ Initial Notification
amendment
=== =============================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================================
a) Name GlaxoSmithKline plc
=== =============================== ====================================================
b) LEI 5493000HZTVUYLO1D793
=== =============================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
=== =============================== ====================================================
b) Nature of the The sale of Ordinary Shares to meet tax
transaction liabilities on nil-cost options over Ordinary
Shares exercised on 22 February 2017 under
the Company's Deferred Annual Bonus Plan
- Deferred Bonus and Matching Awards.
=== =============================== ====================================================
c) Price(s) and volume(s) Price(s) Volume(s)
=== =============================== ================== ============================
GBP16.3850 10,763 (Deferred)
=== =============================== ================== ============================
GBP16.4007 3,589 (Matching)
================== ============================
d) Aggregated information
===
Aggregated volume 14,352
Price GBP16.3889
=== =============================== ====================================================
e) Date of the transaction 2017-02-22
=== =============================== ====================================================
f) Place of the transaction London Stock Exchange (XLON)
=== =============================== ====================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZXLFLDLFEBBE
(END) Dow Jones Newswires
February 23, 2017 09:57 ET (14:57 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024
